MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1
Authors
Keywords
miR-33a, breast cancer, proliferation, metastasis
Journal
Protein & Cell
Volume 6, Issue 12, Pages 881-889
Publisher
Springer Nature
Online
2015-10-27
DOI
10.1007/s13238-015-0223-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patient
- (2015) Stephanie Lu et al. LUNG CANCER
- The past, present and future of breast cancer research in China
- (2014) Wei Hong et al. CANCER LETTERS
- miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways
- (2014) Hui Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST
- (2014) Yong Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- ADAM9 silencing inhibits breast tumor cell invasion in vitro
- (2013) Kelli Cristina Micocci et al. BIOCHIMIE
- Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24
- (2013) Allan Yi Liu et al. CARCINOGENESIS
- Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells
- (2013) Zhuo-Jian Li et al. CELLULAR SIGNALLING
- Tumor metastasis: moving new biological insights into the clinic
- (2013) Liling Wan et al. NATURE MEDICINE
- Periostin: A Bridge between Cancer Stem Cells and Their Metastatic Niche
- (2012) Zhe Wang et al. Cell Stem Cell
- ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
- (2012) Kristin Bergethon et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA
- (2012) S. Volinia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
- (2011) A. F. Ibrahim et al. CANCER RESEARCH
- Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
- (2011) Katey J. Rayner et al. NATURE
- Twist2 contributes to breast cancer progression by promoting an epithelial–mesenchymal transition and cancer stem-like cell self-renewal
- (2011) X Fang et al. ONCOGENE
- The proto-oncogene Pim-1 is a target of miR-33a
- (2011) M Thomas et al. ONCOGENE
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- miR-33 links SREBP-2 induction to repression of sterol transporters
- (2010) T. J. Marquart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
- (2010) S. H. Najafi-Shoushtari et al. SCIENCE
- MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
- (2010) K. J. Rayner et al. SCIENCE
- MicroRNAs: Novel regulators in the hallmarks of human cancer
- (2009) Kai Ruan et al. CANCER LETTERS
- Emerging roles of ADAM and ADAMTS metalloproteinases in cancer
- (2007) N. Rocks et al. BIOCHIMIE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search